Impact of Antiphospholipid Antibodies on COVID-19 Severity and Patient Outcomes

1

COVID-19 can lead to severe respiratory distress and organ failure, often due to a cytokine storm.
2

Antiphospholipid syndrome (APS) is characterized by thrombosis and may be linked to COVID-19 coagulopathy.
3

The study included 95 COVID-19 patients, assessing the impact of antiphospholipid antibodies on disease severity.
4

Severe COVID-19 cases showed a higher mortality rate compared to moderate cases, with 11 deaths in severe patients.
5

Antiphospholipid antibodies may exacerbate COVID-19 severity, indicating a potential area for further research.

Bmc Infectious Diseases

by Batool Zamani, Maedeh Najafizadeh, Atiye Jokar, Habibollah Rahimi, Hossein Motedayyen
January 29, 2026

1